英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
lekr查看　lekr　在百度字典中的解释百度英翻中〔查看〕
lekr查看　lekr　在Google字典中的解释Google英翻中〔查看〕
lekr查看　lekr　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • cdn. clickipo. com
    This is a firm commitment underwritten public offering of 1,162,790 of units (the “Units”), based on an assumed public offering price of $8 60 per Unit (which is based on the last reported sales price of our common stock of $0 215 on April 20, 2021 and assumes a reverse stock split of 1-for-40) of Data Storage Corporation, a Nevada corporation (the “Company”, “we”, “us” or
  • cdn. clickipo. com
    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act (Check one):
  • cbdmd_424b5 - cdn. clickipo. com
    The information in this preliminary prospectus supplement is not complete and may be changed This preliminary prospectus supplement and the accompanying prospectus are part of an effective registration statement filed with the Securities and Exchange Commission under the Securities Act of 1933, as amended This preliminary prospectus supplement and the accompanying prospectus are not an offer
  • 424B5
    This prospectus supplement and the accompanying prospectus dated July 2, 2021 are part of a registration statement that we filed with the Securities and Exchange Commission, or SEC, utilizing a shelf registration process This prospectus supplement and the accompanying prospectus relate to the offer by us of shares of our common stock to certain investors We provide information to you about
  • hpe20210806_s1. htm
    2017 2018 2019 Represents Pure's condensed consolidated balance sheet estimated as of August 21, 2020 after taking into account: (i) the closing of its trust account, (ii) the redemption of Pure's Class A Common Stock by the former public stockholders of Pure that elected to redeem, (iii) paying out the cash consideration to those former public stockholders of Pure who elected to remain and
  • cdn. clickipo. com
    Investing in our securities involves a high degree of risk Before making any investment in these securities, you should consider carefully the risks and uncertainties in the section entitled “Risk Factors” beginning on page 6 of this prospectus, any applicable prospectus supplement and in any applicable free writing prospectuses, and under similar headings in the documents that are
  • 424B5
    We have granted the underwriters an option to purchase up to an additional 750,000 shares of our common stock at the public offering price, less the underwriting discounts and commissions, for a period of 30 days following the date of this prospectus supplement If the underwriters exercise in full their option, the total underwriting discounts and commissions payable by us will be $ , and the
  • cdn. clickipo. com
    The Registrant has included in this Registration Statement a set of alternate pages after the back cover page of the Public Offering Prospectus (the “Alternate Pages”) to reflect the foregoing differences in the Resale Prospectus as compared to the Public Offering Prospectus The Public Offering Prospectus will exclude the Alternate Pages and will be used for the public offering by the
  • cdn. clickipo. com
    Following the IPO Prospectus are certain pages of the prospectus relating solely to such market making transactions (together with the remainder of the prospectus as modified as indicated below, the “Market Making Prospectus”), including an alternate front and back cover page, an alternate table of contents and alternate sections entitled
  • cdn. clickipo. com
    We are a clinical stage biopharmaceutical company, focused on the development and commercialization of novel therapeutics and innovative approaches aimed at intercepting and preventing immune-mediated diseases Since our inception, we have devoted substantially all of our efforts to business planning, research and development, pre-commercial activities, recruiting management and technical





中文字典-英文字典  2005-2009